Tony Vu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tony Vu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Silvana Francesca Marasco
Cardiothoracic Surgery The Alfred Hospital Melbourne Australia
5 shared publications - Yantong Wang
School of Translational Medicine, Monash University, Melbourne, Victoria, Australia
3 shared publications - Varun J. Sharma
Department of Surgery, Melbourne Medical School, University of Melbourne, Melbourne, Australia
2 shared publications - Andrew F. Stephens
Advanced Cardiorespiratory Engineering Laboratory, Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, Australia.
1 shared publication - Andrew J. Taylor
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Vic, Australia
1 shared publication - Christopher Michael Reid
Centre of Clinical Research and Education, Curtin University, Perth, Australia
1 shared publication
Latest Publications
- 20 August 2026
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 35 (11) , 1643-1651
Incidence, Predictors, and Outcomes of Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement
- 20 August 2026
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 35 (11) , 1643-1651
Incidence, Predictors, and Outcomes of Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement
- 9 July 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Incidence and Outcomes of Late Right Heart Failure Following Left Ventricular Assist Device Implantation
Late right heart failure (LRHF) following left ventricular assist device (LVAD) implantation remains an under-recognized complication with significant impact on patient outcomes. We conducted a retrospective cohort study of 183 consecutive LVAD patients at our institution between 2010 and 2024. LRHF was defined according to the 2020 Mechanical Circulatory Support Academic Research Consortium criteria. Clinical, echocardiographic, and perioperative parameters were analyzed with group comparisons and logistic regression, whereas outcomes were evaluated using Kaplan–Meier and competing-risk analyses. LRHF occurred in 17% of patients at a median of 8.8 months following LVAD implantation. Patients with LRHF had larger preoperative right ventricular (RV) basal diameters. Early right heart failure (ERHF) and RV basal diameter were independently associated with LRHF development. LRHF patients had significantly longer intensive care unit and hospital stays, higher rates of chest re-exploration, acute kidney injury, ventricular arrhythmias, and significantly more heart failure-related readmissions. Although overall survival was lower among LRHF patients, it did not reach statistical significance ( p = 0.06). In conclusion, LRHF remains a frequent and morbid complication after LVAD implantation. Early recognition of RV dysfunction may help identify patients at risk of developing LRHF.
- 9 July 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Incidence and Outcomes of Late Right Heart Failure Following Left Ventricular Assist Device Implantation
Late right heart failure (LRHF) following left ventricular assist device (LVAD) implantation remains an under-recognized complication with significant impact on patient outcomes. We conducted a retrospective cohort study of 183 consecutive LVAD patients at our institution between 2010 and 2024. LRHF was defined according to the 2020 Mechanical Circulatory Support Academic Research Consortium criteria. Clinical, echocardiographic, and perioperative parameters were analyzed with group comparisons and logistic regression, whereas outcomes were evaluated using Kaplan–Meier and competing-risk analyses. LRHF occurred in 17% of patients at a median of 8.8 months following LVAD implantation. Patients with LRHF had larger preoperative right ventricular (RV) basal diameters. Early right heart failure (ERHF) and RV basal diameter were independently associated with LRHF development. LRHF patients had significantly longer intensive care unit and hospital stays, higher rates of chest re-exploration, acute kidney injury, ventricular arrhythmias, and significantly more heart failure-related readmissions. Although overall survival was lower among LRHF patients, it did not reach statistical significance ( p = 0.06). In conclusion, LRHF remains a frequent and morbid complication after LVAD implantation. Early recognition of RV dysfunction may help identify patients at risk of developing LRHF.
- 31 October 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (12) , 1456-1463
Use of the Perceval-S Bioprosthesis at an Australian Tertiary Centre
- 31 October 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (12) , 1456-1463
Use of the Perceval-S Bioprosthesis at an Australian Tertiary Centre
- 21 December 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 33 (1) , 92-98
Use of Sutureless Valve in Aortic Root Enlargement
- 21 December 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 33 (1) , 92-98
Use of Sutureless Valve in Aortic Root Enlargement